Design and synthesis of tamoxifen derivatives as a selective estrogen receptor down-regulator
- 1 January 2014
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 24 (1) , 87-89
Abstract
No abstract availableKeywords
Funding Information
- Japan Health Sciences Foundation
This publication has 28 references indexed in Scilit:
- Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancerNature Genetics, 2007
- Estrogen receptors and human diseaseJournal of Clinical Investigation, 2006
- The use of selective estrogen receptor modulators and selective estrogen receptor down-regulators in breast cancerBest Practice & Research Clinical Endocrinology & Metabolism, 2004
- Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells.Endocrine-Related Cancer, 2003
- Molecular Determinants for the Tissue Specificity of SERMsScience, 2002
- Estrogens and cell-cycle regulation in breast cancerTrends in Endocrinology & Metabolism, 2001
- Multifaceted Regulation of Cell Cycle Progression by Estrogen: Regulation of Cdk Inhibitors and Cdc25A Independent of Cyclin D1-Cdk4 FunctionMolecular and Cellular Biology, 2001
- Tamoxifen Therapy for Breast Cancer and Endometrial Cancer RiskJNCI: Journal of the National Cancer Institute, 1999
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trialThe Lancet, 1994